Bill Ackman Supports Valeant’s Allergan Offer

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan in a cash-and-stock deal valued at $45.7 billion that will give the Canadian company the Botox wrinkle treatment. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the offer, Valeant said. Stephanie Ruhle reports on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)
Mila Kunis Helps Miner Become Top Emerald Producer
59:44 - Gemfields CEO Ian Harebottle discusses the gemstone business with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Redfin CEO: How Apple Watch Will Change My Business
  • Is OrangeTheory the Next Big Thing in Fitness Data?
  • Behind the Documentary 'All Eyes and Ears'